Roivant Sciences Ltd. (ROIV)
NASDAQ·Healthcare·Biotechnology
$38.93
+6.27%
Mkt Cap $26.45B
Analyst Ratings
Buy
13
Hold
0
Sell
0
Price Target (34 analysts)
$46.75
Range $40.00 – $55.00
Implied Upside
+20.1%
Consensus $46.75 vs current $38.93
NASDAQ·Healthcare·Biotechnology
$38.93
+6.27%
Mkt Cap $26.45B
Buy
13
Hold
0
Sell
0
Price Target (34 analysts)
$46.75
Range $40.00 – $55.00
+20.1%
Consensus $46.75 vs current $38.93